Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Comparison of PF708 and Forteo in Osteoporosis Patients

ClinicalTrials.gov ID: NCT03002428

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03002428. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 6:34 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Study Comparing the Effects of PF708 and Forteo in Patients With Osteoporosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the effects of two teriparatide products, PF708 and Forteo, in patients with osteoporosis.

Study identification

NCT ID
NCT03002428
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfenex, Inc
Industry
Enrollment
181 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2016 (Actual)
Primary completion
May 2018 (Actual)
Completion
May 2018 (Actual)
Last update posted
May 23, 2018

2016 – 2018

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
Radiant Research Birmingham Alabama 35211 —
The Orthopaedic Group Mobile Alabama 36608 —
Radiant Research Chandler Arizona 85224 —
Radiant Research Mesa Arizona 85213 —
SunValley Arthritis Center Peoria Arizona 85381 —
Radiant Research Phoenix Arizona 85020 —
Radiant Research Colorado Springs Colorado 80909 —
OB-GYN Associates of Mid-Florida Leesburg Florida 34748 —
Atlanta Research Center Atlanta Georgia 30319 —
Radiant Research Chicago Illinois 60602 —
Radiant Research Bridgeton Missouri 63044 —
Radiant Research Papillion Nebraska 68046 —
Radiant Research Henderson Nevada 89074 —
Radiant Research Las Vegas Nevada 89128 —
New Mexico Clinical Research & Osteoporosis Center Albuquerque New Mexico 87106 —
Lillestol Research Fargo North Dakota 58103 —
Radiant Research Akron Ohio 44311 —
Radiant Research Cincinnati Ohio 45236 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Pennsylvania Regional Center for Arthritis & Osteoporosis Research Wyomissing Pennsylvania 19610 —
Radiant Research Dallas Texas 75231 —
Radiant Research Plano Texas 75093 —
Radiant Research San Antonio Texas 78229 —
Radiant Research San Antonio Texas 78240 —
Spectrum Medical Danville Virginia 24541 —
Radiant Research Puyallup Washington 98372 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03002428, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 23, 2018 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.